Artificial intelligence (AI) is increasingly integrated in public health for disease surveillance, behavioral interventions, risk communication, and population health management. However, fragmented oversight and limited equity safeguards can allow AI systems to reinforce existing disparities and create new risks for marginalized populations. A recent analytical essay examines these challenges and outlines strategies for responsible AI use, including equity assessments, community-based validation, transparency, data sovereignty, and human oversight. 

Researchers have developed a recombinant, nanobody-based antivenom that offers broad protection against venom from geographically diverse cobra and king cobra species in India

Chiba University and a Finnish wireless power company will study how wireless power behaves inside an enclosed space as devices enter, leave, and change operating conditions.

In 2024, malignant tumors caused more than 21,300 deaths in Austria, 4.7% more than in 2014. Faced with a similarly pressing global challenge, scientists are striving to better understand what drives cancer cells to grow, spread, and invade healthy tissue. In Science Advances, a team at the Institute of Science and Technology Austria (ISTA) now offers new clues: Using a simplified model, the researchers show how a chaotic environment around tumor cells can promote their invasive behavior. This theoretical concept will need to be examined further in real tumor tissue.

Researchers have created a proof-of-concept, comfortable, wearable EEG headband with embroidered electrodes to monitor brain activity outside the lab

Over three-thousand scientific article titles across disciplines have made use of Beatles song titles and lyrics, according to a study published September 9, 2026, in the open access journal PLOS One by Gabriel Budel of Delft University of Technology in The Netherlands, and colleagues. This analysis is an unprecedentedly large-scale, cross-disciplinary account of how the Beatles have left their mark on scientific writing.

ATLANTA — A multi-institutional research team led by Georgia State University Regents’ Professor Emerita of Biochemistry and Biophysical Chemistry Jenny J. Yang has developed a new class of protein-based MRI contrast agent that detects invasive lung cancer and metastatic disease at earlier stages than conventional imaging approaches. Results of this research, recently published in the journal Science Advances, report a precision MRI method that can identify tumors and metastases as small as 1 millimeter.